인간성장호르몬 시장 규모, 점유율 및 성장 분석 : 제품별, 용도별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global Human Growth Hormone Market size was valued at USD 7.1 Billion in 2024 and is poised to grow from USD 7.97 Billion in 2025 to USD 20.17 Billion by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).

The global human growth hormone market is experiencing robust expansion, driven by advancements in clinical guidelines for treating growth hormone deficiency and innovations in recombinant hormone therapies. Increased accessibility to treatments and heightened awareness of growth hormone insufficiency further propel this growth. Governments and health organizations promote early detection through awareness initiatives, underscoring the importance of addressing this condition. Major companies globally are investing in research and development to create growth hormones with fewer side effects, aligning with emerging market trends. Additionally, there is a concerted effort to effectively treat hormone-related conditions, as human growth hormone plays a vital role in processes like tissue regeneration and cell division, underscoring its significance in overall human growth and health management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Growth Hormone market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Growth Hormone Market Segments Analysis

Global Human Growth Hormone Market is segmented by Product, Application, Distribution Channel and region. Based on Product, the market is segmented into Long Acting and Others. Based on Application, the market is segmented into Growth Hormone (GH) Deficiency, Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age and Other. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy,Online Pharmacyand Specialty Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Growth Hormone Market

The rising incidence of irregular growth patterns, including conditions like Turner syndrome and growth hormone deficiency, significantly influences the global demand for human growth hormone products. As awareness of these conditions increases, earlier diagnosis becomes more common, thereby escalating the need for effective treatments. This trend, combined with improved healthcare access and services, further propels the expansion of the global human growth hormone market. Enhanced education among healthcare professionals and the public also contribute to recognizing the importance of addressing these growth disorders, ultimately leading to a greater emphasis on hormone replacement therapies.

Restraints in the Global Human Growth Hormone Market

The Global Human Growth Hormone market faces challenges due to the presence of alternative treatments for growth disorders. Non-hormonal therapies and lifestyle modifications offer viable options that may provide similar benefits without the need for hormone intervention. As a result, both patients and healthcare providers may prefer these less invasive and often more affordable alternatives. This shift in preference limits the demand for HGH therapies, hindering the growth potential of the market. Consequently, the emergence of various treatment modalities encourages a more cautious approach to HGH usage, creating a significant restraint in the overall market landscape.

Market Trends of the Global Human Growth Hormone Market

The global human growth hormone market is increasingly embracing personalized treatment approaches, reflecting a significant trend towards individualized dosing and delivery techniques. Advancements in biotechnology enable healthcare professionals to tailor growth hormone therapies to meet the specific needs of patients, optimizing therapeutic outcomes while enhancing the overall patient experience. This shift towards customization not only improves efficacy but also fosters stronger patient adherence to treatment protocols. As a result, the market is poised for growth, driven by the rising consumer demand for personalized healthcare solutions that cater to diverse physiological profiles and unique health challenges, ultimately transforming the landscape of growth hormone therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Human Growth Hormone Market Size by Product & CAGR (2026-2033)

• Market Overview
• Long Acting
• Others

Global Human Growth Hormone Market Size by Application & CAGR (2026-2033)

• Market Overview
• Growth Hormone (GH) Deficiency
• Adult GH Deficiency
• Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small For Gestational Age
• Other

Global Human Growth Hormone Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy

Global Human Growth Hormone Market Size & CAGR (2026-2033)

• North America (Product, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech Inc. (USA) (Note: Part of the Roche Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz International GmbH (Germany) (Part of Novartis AG)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Anke Biotechnology (Group) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneScience Pharmaceuticals Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPKO Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascendis Pharma A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Serono Inc. (USA) (Part of Merck KGaA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strongbridge Biopharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Life Sciences (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopartners GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations